What Are the Most Common Side Effects of Wegovy?

Last reviewed: July 3, 2026

Last updated: July 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Wegovy, works by slowing stomach emptying and reducing hunger signals in the brain—effects that often trigger temporary digestive discomfort. Clinical trials show that roughly 40% of patients experience nausea during the first month, but most side effects decrease significantly by week 4 to 8. Understanding what to expect helps you stay on track with your weight loss goals.

How GLP-1 Medications Cause Common Side Effects

Semaglutide activates receptors throughout your digestive tract, which slows how quickly food moves from your stomach into your small intestine. This mechanism is what suppresses appetite and helps with weight loss—but it also triggers nausea, vomiting, and constipation as your body adapts. Your gut lining contains more GLP-1 receptors than any other organ system, making gastrointestinal symptoms the most frequently reported effect in the first weeks of treatment.

The intensity of side effects depends on your starting dose, how quickly it increases, and individual variations in your digestive system sensitivity. Some patients tolerate semaglutide with minimal symptoms, while others experience moderate nausea that peaks around days 3–7 after injection. Dose escalation—gradually increasing your medication amount over 4–16 weeks—is designed specifically to allow your body time to acclimate before reaching therapeutic levels.

Nausea, Vomiting, and Appetite Loss: Timeline and Management

Nausea is the most common side effect, affecting between 20% and 40% of people starting semaglutide therapy depending on the trial reviewed. Most cases are mild to moderate (not severe) and peak in the first week or two after starting or increasing your dose. By week 3 or 4, nausea typically improves by 50% or more, and many patients report it resolves completely by week 8 as their body acclimates to the medication.

To manage nausea, eat smaller meals, avoid high-fat or greasy foods, stay hydrated with electrolyte beverages, and take your injection on the same day each week so your body develops a predictable rhythm. Ginger supplements, vitamin B6, and over-the-counter anti-nausea medications like meclizine can provide relief without interfering with semaglutide's action. If severe vomiting occurs or persists beyond 2 weeks, contact your healthcare provider to discuss dose adjustment or alternative formulations—PlexusDx compounded semaglutide is available both as injection and oral tablet, giving you flexibility if one form causes more side effects.

Constipation and Digestive Changes You Should Expect

Constipation develops in roughly 20%–30% of semaglutide users because the medication slows gastric emptying and reduces overall food intake, leaving less bulk for your colon to move. This side effect typically appears during week 2 to 3 and can persist longer than nausea—sometimes weeks 4–12—as your body adjusts to lower calorie consumption. Unlike nausea, which usually improves on its own, constipation often requires active management through dietary and lifestyle changes.

Increase fiber intake gradually to 25–35 grams daily by eating leafy greens, whole grains, and vegetables; sudden fiber increases can worsen bloating. Drink at least 8–10 glasses of water daily, as semaglutide requires adequate hydration to move through your system effectively. Light walking, gentle stretching, and psyllium husk supplements (like Metamucil) are safe, natural approaches; stool softeners like docusate can help if these measures don't resolve the issue within 1–2 weeks.

Rare but Serious Side Effects and When to Seek Help

While most side effects are mild and temporary, serious complications including pancreatitis, gallbladder inflammation, and severe dehydration occur in less than 1% of patients but demand immediate medical attention. Pancreatitis symptoms include severe upper abdominal pain, back pain, and vomiting that doesn't improve with rest or anti-nausea medication; gallbladder issues present as intense pain in the upper right abdomen, especially after eating. Rapid weight loss—more than 3 pounds per week sustained over multiple weeks—can trigger gallstone formation, which is why steady, gradual weight loss is safer and more sustainable.

Less common side effects include fatigue, headache, dizziness, and muscle weakness, which typically resolve as your body stabilizes at a given dose. Allergic reactions (hives, swelling of lips or tongue, difficulty breathing) are extremely rare with compounded semaglutide from licensed 503A pharmacies, but require emergency care if they occur. If you experience chest pain, shortness of breath, severe diarrhea, or suicidal thoughts, stop taking semaglutide and contact emergency services or poison control immediately.

How Your Genetics Relate to GLP-1 Pathways

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

The test costs $298. Patients with genetic variants showing high GLP1R sensitivity may benefit from starting at lower doses or using the Microdose GLP-1 Protocol ($129/mo), which eases the adjustment period. This personalization approach—rare in standard weight loss care—helps you stay compliant and comfortable while your compounded semaglutide therapy takes effect.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

How long do Wegovy side effects last?

Most side effects peak during the first 1–2 weeks after starting or increasing your dose and improve significantly by week 3–4 as your body adapts. Nausea typically resolves by week 8, while constipation may persist longer and often requires dietary adjustments. If side effects worsen or don't improve after 4 weeks, contact your healthcare provider about dose adjustment.

Can you prevent or reduce nausea on semaglutide?

Yes. Eating smaller, frequent meals; avoiding high-fat foods; staying hydrated; and taking your injection on the same day each week all reduce nausea risk. Ginger supplements, vitamin B6, and meclizine are safe over-the-counter options. Starting at a low dose and increasing gradually—a method PlexusDx recommends—also minimizes early nausea.

Is compounded semaglutide from PlexusDx as safe as brand-name Wegovy?

Yes. PlexusDx sources all compounded semaglutide from licensed 503A compounding pharmacies, which follow strict FDA regulations for sterility, potency, and quality. The active ingredient is identical to Wegovy; the difference is compounding allows flexible dosing, lower cost ($149/mo starting), and access in all 50 states without insurance.

What should I do if I experience severe vomiting on semaglutide?

Severe or persistent vomiting (lasting more than 2 weeks) warrants immediate contact with your provider. PlexusDx offers oral semaglutide ($289/mo) as an alternative to injection if nausea is intolerable, and dose adjustment may help. Always stay hydrated and monitor for signs of dehydration like dark urine or dizziness.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to Wegovy or any specific medication. It analyzes pathway-level variants that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy Side Effects
• Mounjaro Side Effects Plexusdx
• Glp 1 Side Effects Plexusdx
• Tirzepatide Vs Semaglutide Side Effects

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.